Clinical Images: Bilateral eyelid swelling as the presenting feature of Sjögren's disease Authors: Yu‐Chen Jeng, Chun‐Hsin Wu, Julia Yu‐Yun Lee, Sheng‐Chi Yang, Tak‐Wah Wong Published: 2026 (A) The patient, a 52‐year‐old woman, presented with a one‐year history of progressive, bilateral eyelid swelling. This periorbital edema was accompanied by erythema, localized warmth, and classic sicca symptoms, including dry eyes and mild dry mouth. Laboratory evaluation revealed systemic inflammation, including an elevated erythrocyte sedimentation rate of 37 mm/h and a C‐reactive protein level of 11.4 mg/dL, and hypergammaglobulinemia (IgG 2040.0 mg/dL). Immunological workup was positive for speckled antinuclear antibody (1:160), elevated anti‐SSA (29.8 U/mL), and anti‐SSB (15.2 U/mL). Complement levels (C3, C4), rheumatoid factor, and antineutrophil cytoplasmic antibodies were normal, and HIV serology was negative. Although salivary scintigraphy was unremarkable (class I/IV), a Schirmer's test showed impaired tear production (<5 mm in 5 minutes), confirming the diagnosis of Sjögren's disease. 1 To investigate the refractory swelling, an incisional procedure of the right lower eyelid was performed. (B) Histopathology revealed prominent perivascular and periadnexal lymphoplasmacytic infiltration (original magnification ×50, hematoxylin and eosin). 2 Crucially, serum IgG4 levels (67.7 mg/dL; normal range 3.92–86.4 mg/dL) and negative tissue IgG4 staining effectively ruled out IgG4‐related ophthalmic disease. 3 Furthermore, the absence of atypical lymphoid cells on histopathology and a stable clinical course excluded lymphoma. The patient was initiated on concurrent oral prednisolone (30 mg daily) and hydroxychloroquine (200 mg daily). Prednisolone was successfully tapered over 12 weeks while hydroxychloroquine was continued as maintenance therapy. (C) This regimen led to a dramatic and sustained clinical response, with near‐complete resolution of the bilateral eyelid swelling and erythema by week 20. This case highlights the necessity of considering Sjögren's disease and the importance of pathologic examination in the differential diagnosis of chronic, refractory periorbital inflammation. Written informed consent for publication of the clinical details and clinical images was obtained from the patient. The data sets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request. Supported by the Academia Sinica (grant AS‐IDR‐114‐01), the National Science and Technology Council (grant NSTC114‐2314‐B‐006‐071), and National Cheng Kung University Hospital, Taiwan (grant NCKUH‐11404029) Supporting information Disclosure form. Author disclosures are available at https://onlinelibrary.wiley.com/doi/10.1002/acr2.90137. References Associated Data Supplementary Materials Disclosure form.